Madam Speaker, I will be sharing my time with my colleague from Saskatoon West, or as we fondly know him, the member from Saskatoon West Edmonton Mall.
I rise on Bill C-64, which is officially called an act respecting pharmacare. I have two other names for it. One is the proper Liberal name of the bill, which is “fake news to satisfy the gullible NDP caucus act,” and then the longer title is the NDP “I hope no one notices we said we would force an election unless we got a comprehensive and entirely public pharmacare program but sold out for little act.” I am being a bit sarcastic here, but this is the truth.
The government has repeatedly stood in the House and said it is extensive pharmacare, but it is not. It is two items. The NDP members have constantly stood up with their colleagues across the way in the senior partnership, or the radical wing of the NDP, and said it is comprehensive pharmacare that is single pay. Despite what they would have one believe, it would just cover two items.
It does potentially cover diabetes drugs and birth control, but we do not know the details. What it would not do is cover the chronic diseases Canadians are suffering from most. The top ones are hypertension, osteoarthritis, mood and anxiety disorders, osteoporosis, asthma, obstructive pulmonary disease, ischemic heart disease, cancer, dementia and, rounding out the top list, diabetes. Only one item would be covered out of the major chronic issues that are diseases or afflictions hurting Canadians. Where is the coverage for those? It is nowhere to be found, which is why the government and other people in the House should not be calling it a pharmacare act.
The Liberals can name it a potential pharmacare act down the road, but they should not be misleading Canadians into believing that this is a pharmacare act. I asked where the coverage was for hypertension. Eight million Canadians suffer from this. Four million Canadians have osteoarthritis, two million have osteoporosis, and four million are suffering from asthma. How many of them would be covered by this so-called pharmacare act? The answer is zero. Two million Canadians are suffering from obstructive pulmonary disease. Not one would be covered. On ischemic heart disease, 2.4 million Canadians are suffering from this. Not one would be covered under this plan. Forty per cent of Canadians will be diagnosed with cancer in their lifetime, with 250,000 new cases every year. Not one would be covered under this so-called pharmacare act. For dementia, 750,000 people are affected, and not one would be covered. Where is the coverage?
I want to get back to my admittedly snarky comments about the NDP. I want to quote the National Post, which reads, “NDP members drew a line in the sand by passing an emergency resolution at their policy convention in Hamilton...that says the party should withdraw its support if the Liberals do not commit to ‘a universal, comprehensive and entirely public pharmacare program.’”
If one looks up the word “comprehensive”, the definition is, “complete, including all or nearly all aspects of something”. Is this all or nearly all aspects of pharmaceuticals? No, of course it is not. Anne McGrath, the New Democratic Party's national director, “said getting a bill that has teeth will be her party's biggest priority as parliamentarians return to the House of Commons”.
Canada has about 9,000 approved pharmaceutical drugs. The bill would cover maybe 200, so where are the other 8,800? Anne McGrath further stated, “Weak legislation is not going to be acceptable to New Democrats”. Maybe 200 for diabetes and birth control out of 9,000 seems to be acceptable.
She said, “It has to be strong. It has to have teeth. And I feel like that resolution gave [the NDP leader] and the caucus a lot of bargaining power. It gives them a lot of strength.” I wonder when my colleagues in the NDP are going to be withdrawing their support. They probably will not.
One issue I brought up in an earlier question is that a large majority of Canadians are covered, but some are slipping through the cracks. Some are not covered, and some are only partially covered, but they are covered by the province. Alberta, for example, covers most of the items brought up. Essentially, B.C., Quebec and Ontario do as well. Pretty much every province, except one or two in Atlantic Canada, covers diabetes or birth control for low-income Canadians. However, they are not covering the other items of importance, such as hypertension and some of the others.
The initial phase of this is going to cost about a billion and a half dollars. That money could be better used, by either giving it to the provinces for rounding out the services or, better yet, focusing on Canadians afflicted with rare diseases. A couple of families came to my office. Their young children were suffering from SMA, spinal muscular atrophy. It is a horrible disease. Generally, it is a death sentence by the time the child is two years of age. At about the time the children of these two families in Edmonton were diagnosed, a new drug had come out; it is called Spinraza. I have to give points to the pharmaceutical companies for how they come up with these names. Spinraza does not cure the disease, but it extends life to about 18 years old. Children would not have a great quality of life, but they could live to their late teens.
When Spinraza came on the market, Rachel Notley's NDP was in power in Alberta. We went to the local MLAs in the NDP to see if we could speed up coverage for the drug in Alberta; however, the NDP refused to look at this. The same NDP that says it is a line in the sand that it will force an election over refused to help this family. When the provincial United Conservatives were elected, Tyler Shandro was the health minister. He was much maligned, and I am sure a lot of it was probably deserved. However, he managed to get Spinraza approved for the family within two weeks. It is a very expensive drug.
Along came a better drug called Zolgensma. I truly believe it is a miracle drug. With Spinraza, children would spend about a month a year in intensive care, getting spinal taps and everything, for their treatment. Instead of that, Zolgensma is one shot in the arm. It seeks out the bad gene and copy-pastes the good gene over, basically stopping the disease in its track and giving the children a chance at a strong life. It would be about $45 million a year to treat everyone afflicted with this, everyone born every year in Canada. This is where the government should spend this money. It should focus on that.
It should not be spending money to replace programs that already exist. About 60% of Canadians have a program delivered through work. Instead of subsidizing that 60%, it should look after people like this in need. These two families had to fundraise for this drug. Ryan Reynolds, who was in Deadpool, helped fundraise for these two families. Luckily enough, a corporate benefactor came through and provided for everyone in Canada. This is an example where that billion and a half dollars could be better spent.
Another couple in my riding had a child suffering from PKU, which is a rare inherited disorder. It causes a buildup in amino acid in the body and prevents it from metabolizing protein. Children cannot have protein. It costs $5,000 a month out-of-pocket. The government should look after covering this.
Twenty-seven million Canadians already have coverage through work. This Liberal single-payer plan is going to subsidize either the companies that are already paying for this or big pharma. It is funny that big pharma just got an extra tax for too much profit through the Liberal government, a temporary Canada recovery dividend to attack big pharma, which it is now going to subsidize. It could also subsidize companies directly, including Loblaws. At the same time as it is demonizing Loblaws in the House, it will end up subsidizing it. Therefore, I do not support the act as it is. There are better ways to do it than the way the Liberals and NDP are doing it.
